Report cover image

Global Lafutidine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 188 Pages
SKU # APRC20278238

Description

Summary

According to APO Research, The global Lafutidine Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lafutidine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lafutidine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Lafutidine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Lafutidine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Lafutidine Tablets include Yuekang Pharmaceutical Group Co., Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., Shandong Qidu Pharmaceutical Co., Ltd., Jiangsu Runbang Pharmaceutical Co., Ltd., China Resources Double Crane Pharmaceutical Co., Ltd., Hubei Shubang Pharmaceutical Co., Ltd. and Chengdu Hengrui Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lafutidine Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Lafutidine Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Lafutidine Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lafutidine Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lafutidine Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Lafutidine Tablets sales, projected growth trends, production technology, application and end-user industry.

Lafutidine Tablets Segment by Company

Yuekang Pharmaceutical Group Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd.
Shandong Qidu Pharmaceutical Co., Ltd.
Jiangsu Runbang Pharmaceutical Co., Ltd.
China Resources Double Crane Pharmaceutical Co., Ltd.
Hubei Shubang Pharmaceutical Co., Ltd.
Chengdu Hengrui Pharmaceutical Co., Ltd.
Lafutidine Tablets Segment by Type

10mg
5mg
Lafutidine Tablets Segment by Application

Hospital
Clinic
Other
Lafutidine Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lafutidine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lafutidine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lafutidine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lafutidine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lafutidine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lafutidine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Lafutidine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

188 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Lafutidine Tablets Market Size, 2020 VS 2024 VS 2031
1.3 Global Lafutidine Tablets Market Size Estimates and Forecasts (2020-2031)
1.4 Global Lafutidine Tablets Sales Estimates and Forecasts (2020-2031)
1.5 Global Lafutidine Tablets Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Lafutidine Tablets Market Dynamics
2.1 Lafutidine Tablets Industry Trends
2.2 Lafutidine Tablets Industry Drivers
2.3 Lafutidine Tablets Industry Opportunities and Challenges
2.4 Lafutidine Tablets Industry Restraints
3 Lafutidine Tablets Market by Manufacturers
3.1 Global Lafutidine Tablets Revenue by Manufacturers (2020-2025)
3.2 Global Lafutidine Tablets Sales by Manufacturers (2020-2025)
3.3 Global Lafutidine Tablets Average Sales Price by Manufacturers (2020-2025)
3.4 Global Lafutidine Tablets Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Lafutidine Tablets Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Lafutidine Tablets Manufacturers, Product Type & Application
3.7 Global Lafutidine Tablets Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Lafutidine Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Lafutidine Tablets Players Market Share by Revenue in 2024
3.8.3 2024 Lafutidine Tablets Tier 1, Tier 2, and Tier 3
4 Lafutidine Tablets Market by Type
4.1 Lafutidine Tablets Type Introduction
4.1.1 10mg
4.1.2 5mg
4.2 Global Lafutidine Tablets Sales by Type
4.2.1 Global Lafutidine Tablets Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Lafutidine Tablets Sales by Type (2020-2031)
4.2.3 Global Lafutidine Tablets Sales Market Share by Type (2020-2031)
4.3 Global Lafutidine Tablets Revenue by Type
4.3.1 Global Lafutidine Tablets Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Lafutidine Tablets Revenue by Type (2020-2031)
4.3.3 Global Lafutidine Tablets Revenue Market Share by Type (2020-2031)
5 Lafutidine Tablets Market by Application
5.1 Lafutidine Tablets Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Lafutidine Tablets Sales by Application
5.2.1 Global Lafutidine Tablets Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Lafutidine Tablets Sales by Application (2020-2031)
5.2.3 Global Lafutidine Tablets Sales Market Share by Application (2020-2031)
5.3 Global Lafutidine Tablets Revenue by Application
5.3.1 Global Lafutidine Tablets Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Lafutidine Tablets Revenue by Application (2020-2031)
5.3.3 Global Lafutidine Tablets Revenue Market Share by Application (2020-2031)
6 Global Lafutidine Tablets Sales by Region
6.1 Global Lafutidine Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Lafutidine Tablets Sales by Region (2020-2031)
6.2.1 Global Lafutidine Tablets Sales by Region (2020-2025)
6.2.2 Global Lafutidine Tablets Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Lafutidine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Lafutidine Tablets Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Lafutidine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Lafutidine Tablets Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Lafutidine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Lafutidine Tablets Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Lafutidine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Lafutidine Tablets Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Lafutidine Tablets Revenue by Region
7.1 Global Lafutidine Tablets Revenue by Region
7.1.1 Global Lafutidine Tablets Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Lafutidine Tablets Revenue by Region (2020-2025)
7.1.3 Global Lafutidine Tablets Revenue by Region (2026-2031)
7.1.4 Global Lafutidine Tablets Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Lafutidine Tablets Revenue (2020-2031)
7.2.2 North America Lafutidine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Lafutidine Tablets Revenue (2020-2031)
7.3.2 Europe Lafutidine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Lafutidine Tablets Revenue (2020-2031)
7.4.2 Asia-Pacific Lafutidine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Lafutidine Tablets Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Lafutidine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Yuekang Pharmaceutical Group Co., Ltd.
8.1.1 Yuekang Pharmaceutical Group Co., Ltd. Comapny Information
8.1.2 Yuekang Pharmaceutical Group Co., Ltd. Business Overview
8.1.3 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Yuekang Pharmaceutical Group Co., Ltd. Lafutidine Tablets Product Portfolio
8.1.5 Yuekang Pharmaceutical Group Co., Ltd. Recent Developments
8.2 Sichuan Kelun Pharmaceutical Co., Ltd.
8.2.1 Sichuan Kelun Pharmaceutical Co., Ltd. Comapny Information
8.2.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
8.2.3 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sichuan Kelun Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
8.2.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
8.3 Shandong Qidu Pharmaceutical Co., Ltd.
8.3.1 Shandong Qidu Pharmaceutical Co., Ltd. Comapny Information
8.3.2 Shandong Qidu Pharmaceutical Co., Ltd. Business Overview
8.3.3 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Shandong Qidu Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
8.3.5 Shandong Qidu Pharmaceutical Co., Ltd. Recent Developments
8.4 Jiangsu Runbang Pharmaceutical Co., Ltd.
8.4.1 Jiangsu Runbang Pharmaceutical Co., Ltd. Comapny Information
8.4.2 Jiangsu Runbang Pharmaceutical Co., Ltd. Business Overview
8.4.3 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Jiangsu Runbang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
8.4.5 Jiangsu Runbang Pharmaceutical Co., Ltd. Recent Developments
8.5 China Resources Double Crane Pharmaceutical Co., Ltd.
8.5.1 China Resources Double Crane Pharmaceutical Co., Ltd. Comapny Information
8.5.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
8.5.3 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 China Resources Double Crane Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
8.5.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
8.6 Hubei Shubang Pharmaceutical Co., Ltd.
8.6.1 Hubei Shubang Pharmaceutical Co., Ltd. Comapny Information
8.6.2 Hubei Shubang Pharmaceutical Co., Ltd. Business Overview
8.6.3 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Hubei Shubang Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
8.6.5 Hubei Shubang Pharmaceutical Co., Ltd. Recent Developments
8.7 Chengdu Hengrui Pharmaceutical Co., Ltd.
8.7.1 Chengdu Hengrui Pharmaceutical Co., Ltd. Comapny Information
8.7.2 Chengdu Hengrui Pharmaceutical Co., Ltd. Business Overview
8.7.3 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Chengdu Hengrui Pharmaceutical Co., Ltd. Lafutidine Tablets Product Portfolio
8.7.5 Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Lafutidine Tablets Value Chain Analysis
9.1.1 Lafutidine Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Lafutidine Tablets Production Mode & Process
9.2 Lafutidine Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Lafutidine Tablets Distributors
9.2.3 Lafutidine Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.